Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]

Naoki Haratake; Hiroki Ozawa; Yoshihiro Morimoto; Nami Yamashita; Tatsuaki Daimon; Atrayee Bhattacharya; Keyi Wang; Ayako Nakashoji; Hideko Isozaki; Mototsugu Shimokawa; Chie Kikutake; Mikita Suyama; Asato Hashinokuchi; Kazuki Takada; Tomoyoshi Takenaka; Tomoharu Yoshizumi; Tetsuya Mitsudomi; Aaron N. Hata; Donald Kufe

doi:10.1016/j.jtho.2024.12.004

Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]

Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Ayako Nakashoji, Hideko Isozaki, Mototsugu Shimokawa, Chie Kikutake, Mikita Suyama, Asato Hashinokuchi, Kazuki Takada, Tomoyoshi Takenaka, Tomoharu Yoshizumi, Tetsuya Mitsudomi, Aaron N. Hata, Donald Kufe

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

抄録

The published version of this article contained an error in Fig. 4C, which does not affect the conclusions of the research. Using Proofig AI following publication, the authors found that the same image for p-EGFR was inadvertently included in Figs. 4A and 4C. The corrected version for Fig. 4C is provided below.[Figure

本文言語	英語
ページ（範囲）	399
ページ数	1
ジャーナル	Journal of Thoracic Oncology
巻	20
号	3
DOI	https://doi.org/10.1016/j.jtho.2024.12.004
出版ステータス	出版済み - 3月 2025

!!!All Science Journal Classification (ASJC) codes

腫瘍学
呼吸器内科

文献へのアクセス

10.1016/j.jtho.2024.12.004

他のファイルとリンク

フィンガープリント

「Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Haratake, N., Ozawa, H., Morimoto, Y., Yamashita, N., Daimon, T., Bhattacharya, A., Wang, K., Nakashoji, A., Isozaki, H., Shimokawa, M., Kikutake, C., Suyama, M., Hashinokuchi, A., Takada, K., Takenaka, T., Yoshizumi, T., Mitsudomi, T., Hata, A. N., & Kufe, D. (2025). Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]. Journal of Thoracic Oncology, 20(3), 399. https://doi.org/10.1016/j.jtho.2024.12.004

Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]. / Haratake, Naoki; Ozawa, Hiroki; Morimoto, Yoshihiro その他.
In: Journal of Thoracic Oncology, Vol. 20, No. 3, 03.2025, p. 399.

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

Haratake, N, Ozawa, H, Morimoto, Y, Yamashita, N, Daimon, T, Bhattacharya, A, Wang, K, Nakashoji, A, Isozaki, H, Shimokawa, M, Kikutake, C, Suyama, M, Hashinokuchi, A, Takada, K , Takenaka, T , Yoshizumi, T, Mitsudomi, T, Hata, AN & Kufe, D 2025, 'Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]', Journal of Thoracic Oncology, vol. 20, no. 3, pp. 399. https://doi.org/10.1016/j.jtho.2024.12.004

@article{d1b89ee133944af382e2ca5d6e494bca,

title = "Corrigendum to {\textquoteleft}MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC{\textquoteright} [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]",

abstract = "The published version of this article contained an error in Fig. 4C, which does not affect the conclusions of the research. Using Proofig AI following publication, the authors found that the same image for p-EGFR was inadvertently included in Figs. 4A and 4C. The corrected version for Fig. 4C is provided below.[Figure",

author = "Naoki Haratake and Hiroki Ozawa and Yoshihiro Morimoto and Nami Yamashita and Tatsuaki Daimon and Atrayee Bhattacharya and Keyi Wang and Ayako Nakashoji and Hideko Isozaki and Mototsugu Shimokawa and Chie Kikutake and Mikita Suyama and Asato Hashinokuchi and Kazuki Takada and Tomoyoshi Takenaka and Tomoharu Yoshizumi and Tetsuya Mitsudomi and Hata, {Aaron N.} and Donald Kufe",

note = "Publisher Copyright: {\textcopyright} 2024 International Association for the Study of Lung Cancer",

year = "2025",

month = mar,

doi = "10.1016/j.jtho.2024.12.004",

language = "English",

volume = "20",

pages = "399",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]

AU - Haratake, Naoki

AU - Ozawa, Hiroki

AU - Morimoto, Yoshihiro

AU - Yamashita, Nami

AU - Daimon, Tatsuaki

AU - Bhattacharya, Atrayee

AU - Wang, Keyi

AU - Nakashoji, Ayako

AU - Isozaki, Hideko

AU - Shimokawa, Mototsugu

AU - Kikutake, Chie

AU - Suyama, Mikita

AU - Hashinokuchi, Asato

AU - Takada, Kazuki

AU - Takenaka, Tomoyoshi

AU - Yoshizumi, Tomoharu

AU - Mitsudomi, Tetsuya

AU - Hata, Aaron N.

AU - Kufe, Donald

PY - 2025/3

Y1 - 2025/3

N2 - The published version of this article contained an error in Fig. 4C, which does not affect the conclusions of the research. Using Proofig AI following publication, the authors found that the same image for p-EGFR was inadvertently included in Figs. 4A and 4C. The corrected version for Fig. 4C is provided below.[Figure

AB - The published version of this article contained an error in Fig. 4C, which does not affect the conclusions of the research. Using Proofig AI following publication, the authors found that the same image for p-EGFR was inadvertently included in Figs. 4A and 4C. The corrected version for Fig. 4C is provided below.[Figure

UR - http://www.scopus.com/inward/record.url?scp=85212439207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85212439207&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2024.12.004

DO - 10.1016/j.jtho.2024.12.004

M3 - Comment/debate

C2 - 39692639

AN - SCOPUS:85212439207

SN - 1556-0864

VL - 20

SP - 399

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 3

ER -